Sentences with phrase «cells from a developing»

It's now known that cells from a developing fetus cross the placenta, allowing the baby's DNA to become part of the mother's body.

When a woman is pregnant, cells from the developing fetus often enter the mother's bloodstream, and some of them even set up long - term residence.

About three - fourths of renal cell carcinoma cases are marked by a missing VHL tumor - suppressor gene, which keeps healthy cells from developing into tumors.

Currently U.K. law forbids allowing human embryos containing animal cells from developing longer than 14 days.

Such rapid and extensive degradation suggests that conjugates may be able to prevent or hinder cancer cells from developing resistance to targeted therapies, the researchers state.

Understanding the processes that restrain mutant cells from developing into tumours, and how they are breached when cancers do form will guide the development of strategies to reduce the chance of cancer development in individuals who have acquired a high level of mutations.

In vitro expanded stem cells from the developing retina fail to generate photoreceptors but differentiate into myelinating oligodendrocytes.

This special carrier can also be potentially used to co-deliver therapeutic nucleic acids to prevent cancer cells from developing resistance to multiple drugs4.

Among other things, having regular orgasms has been proved to be beneficial for a wide range of things, going from making you look younger, protecting your cardiovascular health, reducing stress, over boosting your immune system, all the way up to lowering rates of depression, and anxiety, and even possibly preventing breast cancer cells from developing into a tumor.

Another study from the Department of Human Oncology, University of Wisconsin - Madison, stated that the monoterpene d - limonene found in large quantities in certain therapeutic essential oils has been shown to prevent abnormal cells from developing.

Not exact matches

The company is developing a T - cell reprogramming technology designed to generate an anti-tumor response from the patient's own immune system.

Scientists have identified as many as 80 others, which range from type 1 diabetes, which develops when the body attacks its insulin - producing cells, to multiple sclerosis, psoriasis, and rheumatoid arthritis.

Honda established a division late last year to develop electric vehicles (EVs) as part of its long - held goal for lower - emission gasoline hybrids, plug - in hybrids, EVs and hydrogen fuel cell vehicles (FCVs) to account for two - thirds of its line - up by 2030, from about 5 percent now.

Instead, LaFlamme's research team in Toronto is taking a different approach through injecting a billion heart - muscle cells (otherwise known as cardiomyocytes) that have been developed from stem cells.

One way to enhance eggs, developed by the company OvaScience, involves supplementing an egg with mitochondria taken from stem cells found in the lining of a woman's uterus.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

While startups like Impossible Foods are focused on developing plant - based alternatives to the proteins that give meat its flavor, Future Meat Technologies and Memphis Meats are trying to use animal cells themselves to grow meat, rather than basically harvesting it from dead animals.

Scientists from the University of Wollongong have developed prototype battery cells based on sodium - ion technology, which the university says can achieve excellent cycling stability and easily be scaled up to mass production.

A note from Axiom Capital is saying Tesla is in talks with Swiss photovoltaics firm Meyer Burger to develop solar cell technology...

One thing that many Christians get hung up on is the idea of evolution as a belief that we all developed from single celled organisms and that our genetic map split from apes and etc..

In The Liberation of Life: From the Cell to the Community, one of the most creative encounters between science and the relational vision, John B. Cobb, Jr., a process theologian, and Charles Birch, an Australian biologist and quite a lay theologian of the process persuasion in his own right, develop an ecological, relational view of reality and the sciences.

To develop this sense of «belonging» will be a way in which, here and now, life can become meaningful; for in the little cells of Christian faith and love which are our parishes as they ought to be, hope is implanted m men's hearts that lifts them above, and yet sends them back into, the community life of which they are also a part, knowing that they have passed from death into life, because they love the brethren and are therefore empowered to bring a stream of fresh, courageous, loving life to a sadly disillusioned and despairing world.

Under Child's theory there is complete continuity from the reaction of the cell with its environment, which constitutes the primary metabolic gradient, and from the later reactions, by which the pattern of the developing embryo is laid down in accordance with the changing gradient pattern, to the intellectual processes by which the adult organism adjusts its relations to the outside world.

From it will develop:... 60 trillion cells, 100 thousand miles of nerve fiber, 60 thousand miles of vessels carrying blood around the body, 250 bones, to say nothing of joints, ligaments and muscles.

From this apparently undifferentiated mass of cells a stalk grows at the top of which a fruiting body is formed that develops spores.

This module is developed for customers that want the benefits from using Eilersen digital load cells but can not change existing equipment designed for analog strain gage load cells [more]

The lab - grown meat — which the company calls «clean meat» — is developed from self - reproducing cells taken from a chicken, with the purpose of creating a product that omnivores can't distinguish from the real thing, but with a fraction of the considerable downsides of meat production, including environmental destruction and using agricultural land to grow animal feed rather than crops for human consumption.

Over the course of about forty weeks, the baby grows and matures from those two cells to a fully developed baby and is born.

When the mature eggs, which have been retrieved from a woman's ovaries, have been successfully fertilized the resulting embryos begin to develop through rapid cell division.

This injection contains antibodies that will help kill off any of your baby's red blood cells that may have entered your blood stream, thereby preventing your body from developing its own antibodies to your baby's blood.

Embryo: All of your babies» organs and body parts will develop from the two layers of cells that now make up the embryo: the epiblast and the hypoblast.

Aside from the nourishing prebiotic, it also designed the OptiGRO, a unique blend of DHA, Lutein and Vitamin E, to support brain development, eye health, and developing cells, respectively.

Interestingly, Mom's cells have developed countermeasures to protect themselves from the baby's cellular demands.

Between May 2012 and May 2013 he earned # 43,400 from AFC Energy, a company developing alkaline fuel cell technology, for his role chairing its board.

While scientists have previously had success in 3D printing a range of human stem cell cultures developed from bone marrow or skin cells, a team from Scotland's Heriot - Watt University claims to be the first to print the more delicate, yet more flexible, human embryonic stem cells (hESCs).

With cutting - edge techniques from genetics to stem cell therapy - and life - saving drugs to prevent, alleviate or cure conditions like Alzheimer's - likely to be developed in the years ahead, what seem medical miracles today will be medically routine tomorrow.

«To keep a female from remating, the males have developed a hard outer shell around the precious nutrients that are especially desirable by females to repair their cells and live longer,» says Clark.

Since the first human brain organoids were created from stem cells in 2013, scientists have gotten them to form structures like those in the brains of fetuses, to sprout dozens of different kinds of brain cells, and to develop abnormalities like those causing neurological diseases such as Timothy syndrome.

While the Vortex system is designed specifically for blood, the company is working with academic researchers to develop versions that could be used to isolate cells from other body fluids as well, such as cerebrospinal fluid and urine.

To develop their «disease in a dish» model, the team took skin cells from patients with Allan - Herndon - Dudley syndrome and reprogrammed them into induced pluripotent stem cells, which then can be developed into any type of tissue in the body.

Injections of killed stem cells, designed to help the immune system recognise cancers, have been found to protect mice from developing tumours

Extracts from seven of the 11 dust samples triggered the pre-adipocytes to develop into mature fat cells and accumulate triglycerides.

«We have developed a drug candidate, a next - generation biologic medical product, and are now publishing the fantastic results from the preclinical part where wound healing was strongly accelerated in mice,» says Mia Phillipson, Professor at the Department of Medical Cell Biology, Division of Integrative Physiology, Uppsala University.

Now, a collaborative team of scientists at Washington University in St. Louis has developed a new process to generate NP - like cells from hiPSCs, one that truly goes back to the beginning and mimics the process of embryonic development.

Each of us develops from an unspecialized single cell into hundreds of different specific cell types.

The researchers developed a glass coating that incorporates ultrathin nanorods and honeycomb nanowalls that can help underlying solar cells harvest sunlight from multiple angles.

The RNA molecules intermingle on a threadlike network that allows them to move from one nurse cell to another and then into the developing egg (which we don't see in this image).

Advanced Cell Technology, based in Santa Monica California, is developing embryonic stem cell therapies for macular degeneration and other conditions using cells obtained non-destructively from an early embryo called a blastocCell Technology, based in Santa Monica California, is developing embryonic stem cell therapies for macular degeneration and other conditions using cells obtained non-destructively from an early embryo called a blastoccell therapies for macular degeneration and other conditions using cells obtained non-destructively from an early embryo called a blastocyst.

Researchers from the Institute for Integrated Cell - Material Sciences (iCeMS) of Kyoto University and the Department of Cardiovascular Surgery of Osaka University have developed effective and convenient Cardiac Tissue - Like Constructs (CTLCs) for repairing myocardial infarctions.

Now researchers are attempting to resolve this issue by developing solar cells that can harvest light from almost any angle, and the panels self - clean to boot.